Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting.
Journal: Experimental eye research
Published: March 07, 2020
Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy.
Journal: Investigative ophthalmology & visual science
Published: July 20, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026